Sabra Health Care REIT, Inc.
SBRA
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 72.61 | 127.49% |
| 2024 | 31.92 | -86.69% |
| 2023 | 239.84 | -748.38% |
| 2022 | -36.99 | 41.24% |
| 2021 | -26.19 | -201.20% |
| 2020 | 25.88 | -55.30% |
| 2019 | 57.89 | 449.82% |
| 2018 | 10.53 | -15.88% |
| 2017 | 12.52 | -44.82% |
| 2016 | 22.69 | 43.09% |
| 2015 | 15.85 | -47.12% |
| 2014 | 29.98 | 3.08% |
| 2013 | 29.09 | -29.49% |
| 2012 | 41.25 | 45.53% |
| 2011 | 28.35 | -54.90% |
| 2010 | 62.85 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 120.30 | 65.66% |
US
|
|
| 153.29 | 111.10% |
US
|
|
| 15.60 | -78.51% |
US
|
|
| 53.54 | -26.26% |
US
|
|
| 77.01 | 6.05% |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.